Bu+Vp16预处理方案行自体造血干细胞移植治疗急性髓系白血病27例临床疗效分析

详细信息

收稿日期: 2017-12-28

Efficacy and safety of Bulsulphan and Etoposide conditioning regimen in autologous hematopoietic stem cell transplantation for 27 acute myeloid leukemia cases

More Information

Received Date: 28 December 2017

[1]	Vellenga E, van Putten W, Ossenkoppele GJ, et al.Autologous peripheral blood stem cell transplantation for acute myeloid leukemia[J].Blood, 2011, 118:6037-6042.
[2]	Godder K, Eapen M, Laver JH, et al.Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission:a prognostic factor analysis[J].J Clin Oncol, 2004, 22:3798-3804.
[3]	Pfirrmann M, Ehninger G, Thiede C, et al.Prediction of post-remission survival in acute myeloid leukemia:a post-hoc analysis of the AML 96 trial[J].Lancet Oncol, 2012, 13:207-214.
[4]	Hong M, Miao KR, Zhang R, et al.High-dose idarubicin plus buslfan as conditioning regimen to autologous stem cell transplantation:Promising post-remission therapy for acute myeloid leukemia in first complete remission[J].Med Oncol, 2014, 31:980-984.
[5]	程英英, 王彪, 曹香山, 等.IBU预处理方案行自体造血干细胞移植治疗急性髓系白血病10例的临床疗效[J].临床血液学杂志, 2015, 28(3):241-243.